Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08KYP
|
|||
Drug Name |
Hydroxyqunoline analog 5
|
|||
Synonyms |
PMID25468267-Compound-45
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C29H36N4O2
|
|||
Canonical SMILES |
CN(C)CC1CCN(CC1)C2CCN(CC2)C(=O)C3=CC=CC(=C3)C4=CC(=C5C(=C4)C=CC=N5)O
|
|||
InChI |
1S/C29H36N4O2/c1-31(2)20-21-8-13-32(14-9-21)26-10-15-33(16-11-26)29(35)24-6-3-5-22(17-24)25-18-23-7-4-12-30-28(23)27(34)19-25/h3-7,12,17-19,21,26,34H,8-11,13-16,20H2,1-2H3
|
|||
InChIKey |
CILGUWSVIMKGON-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Lysine-specific demethylase 4E (KDM4E) | Target Info | Inhibitor | [1] |
Target's Patent Info | Lysine-specific demethylase 4E (KDM4E) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.